Chemotaxis and transendothelial migration of CD34+ hematopoietic progenitor cells induced by the inflammatory mediator leukotriene D4 are mediated by the 7-transmembrane receptor CysLT1

Blood

Volumn 97, Issue 11, 2001, Pages 3433-3440

  Bautz, Frank ^a   Denzlinger, Claudio ^a   Kanz, Lothar ^a   Möhle, Robert ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CD34 ANTIGEN; CHEMOKINE; LEUKOTRIENE; LEUKOTRIENE D4; MEMBRANE RECEPTOR; PEPTIDOLEUKOTRIENE; PERTUSSIS TOXIN; PROTEIN CYSLT1; UNCLASSIFIED DRUG; VERLUKAST;

ACTIN POLYMERIZATION; ALLERGY; ARTICLE; AUTOCRINE EFFECT; CALCIUM TRANSPORT; CELL MIGRATION; CHEMOTAXIS; GRANULOCYTE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INFLAMMATION; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL;

EID: 0035383811     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.11.3433     Document Type: Article

References (58)

1. Zanjani ED, Flake AW, Almeida-Porada G, Tran N, Papayannopoulou T. Homing of human cells in the fetal sheep model: modulation by antibodies activating or inhibiting very late activation antigen-4-dependent function. Blood. 1999;94:2515-2522.
2. Naiyer AJ, Jo DY, Ahn J, et al. Stromal derived factor-1-induced chemokinesis of cord blood CD34+ cells (long-term culture-initiating cells) through endothelial cells is mediated by E-selectin. Blood. 1999;94:4011-4019.
3. Greenberg AW, Kerr WG, Hammer DA. Relationship between selectin-mediated rolling of hematopoietic stem and progenitor cells and progression in hematopoietic development. Blood. 2000; 95:478-486.
4. Möhle R, Bautz F, Rafii S, Moore MAS, Brugger W, Kanz L. Regulation of transendothelial migration of hematopoietic progenitor cells. Ann N Y Acad Sci. 1999;872:176-186.
5. Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC. The chemokine SDF-1 is a chemoattractant for human hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med. 1997;185:111-120.
6. Möhle R, Bautz F, Rafii S, Moore MA, Brugger W, Kanz L. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood. 1998;91:4523-4530.
7. Peled A, Petit I, Kollet O, et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR-4. Science. 1999;283: 845-848.
8. Jacobsen K, Kravitz J, Kincade PW, Osmond DG. Adhesion receptors on bone marrow stromal cells: in vivo expression of vascular cell adhesion molecule-1 by reticular cells and sinosoidal endothelium in normal and gamma-irradiated mice. Blood. 1996;87:73-82.
9. Schweitzer KM, Drager AM, vanderValk P, et al. Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues. Am J Pathol. 1996;148: 165-175.
10. Denzlinger C. Biology and pathophysiology of leukotrienes. Crit Rev Oncol Hematol. 1996;23: 167-223.
11. Ford-Hutchinson AW, Gresser M, Young RN. 5-Lipoxygenase. Annu Rev Biochem. 1994;63:282-417.
12. Lynch KR, O'Neill GP, Liu Q, et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature. 1999;399:789-793.
13. Yokomizu T, Izumi T, Chang K, Takuwa Y, Shimizu T. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature. 1997;387:620-624.
14. Lindgren JA, Stenke L, Mansour M, et al. Formation and effects of leukotrienes and lipoxins in human bone marrow. J Lipid Mediat. 1993;6:313-320.
15. Dupuis F, Desplat V, Praloran V, Denizot Y. Effects of lipidic mediators on the growth of human myeloid and erythroid marrow progenitors. J Lipid Mediat Cell Signal. 1997;16:117-125.
16. Panettieri RA, Tan EM, Ciocca V, Luttmann MA, Leonard TB, Hay DW. Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction in vitro: differential sensivity to cysteinyl leukotriene receptor antagonists. Am J Respir Cell Mol Biol. 1998;19:453-461.
17. Spada CS, Nieves AL, Krauss AH, Woodward DF. Comparison of leukotriene B4 and D4 effects on human eosinophil and neutrophil motility in vitro. J Leukoc Biol. 1994;55:183-191.
18. Chan CC, McKee K, Tagari P, Chee P, Ford-Hutchinson A. Eosinophil-eicosanoid interactions: inhibition of eosinophil chemotaxis by a LTD4-receptor antagonist. Eur J Pharmacol. 1990;191: 273-280.
19. Dahlen SE, Hedqvist P, Hammarstrom S, Samuelsson B. Leukotrienes are potent constrictors of human bronchi. Nature. 1980;288:484-486.
20. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human diseases. N Engl J Med. 1990;323: 645-655.
21. Sarau HM, Ames RS, Chambers J, et al. Identification, molecular cloning, and characterization of a cysteinyl leukotriene receptor. Mol Pharmacol. 1999;56:657-663.
22. Bleul CC, Farzan M, Choe H, et al. The lymphocyte chemoattractant SDF-1 is a ligand for lestr/ fusin and blocks HIV-1 entry. Nature. 1996;382: 829-832.
23. Oberlin E, Amara A, Bachelerie F, et al. The CXC chemokine SDF-1 is the ligand for lestr/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature. 1996;382:833-835.
24. Metters KM, Zamboni RJ. Photoaffinity labeling of the leukotriene D4 receptor in guinea pig lung. J Biol Chem. 1993;268:6487-6495.
25. Hoshino M, Izumi T, Shimizu T. Leukotriene D4 activates mitogen-activated protein kinase through a protein kinase Calpha-Raf-1-dependent pathway in human monocytic leukemia THP-1 cells. J Biol Chem. 1998;273:4878-4882.
26. Crooke ST, Mattern M, Sarau HM, et al. The signal transduction system of the leukotriene D4 receptor. Trends Pharmacol Sci. 1989;10:103-107.
27. Chan CC, Ecclestone P, Nicholson DW, Metters KM, Pon DJ, Rodger IW. Leukotriene D4-induced increases in cytosolic calcium in THP-1 cells: dependence on extracellular calcium and inhibition with selective leukotriene D4 receptor antagonists. J Pharmacol Exp Ther. 1994;269:891-896.
28. Jones TR, Zamboni R, Belley M, et al. Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist. Can J Physiol Pharmacol. 1989;67:17-28.
29. Jarvis B, Markham A. Montelukast: a review of its therapeutic potential in persistent asthma. Drugs. 2000;59:891-928.
30. Jones TR, Rodger IW. Role of leukotrienes and leukotriene receptor antagonists in asthma. Pulm Pharmacol Ther. 1999;12:107-110.
31. Kohrogi H, Iwagoe H, Fujii K, et al. The role of cysteinyl leukotrienes in the pathogenesis of asthma: clinical study of leukotriene antagonist pranlukast for 1 year in moderate and severe asthma. Respirology. 1999;4:319-323.
32. Hamilton A, Faiferman I, Stober P, Watson RM, O'Byrne PM. Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects. J Allergy Clin Immunol. 1998;102:177-183.
33. Heise CE, O'Dowd BF, Figueroa DJ, et al. Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem. 2000;275:30531-30536.
34. Meister B, Grünebach F, Bautz F, et al. Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma. Eur J Cancer. 1999;35:445-449.
35. Dexter TM, Testa NG. In vitro methods in hematopoiesis and lymphopoiesis. J Immunol Methods. 1980;38:177-190.
36. Boyum A. Isolation of lymphocytes, granulocytes and macrophages. Scand J Immunol. 1976; (suppl 5):9-15.
37. Andersen BR, Brendzel AM. Use of a unique chemiluminescence spectrometer in a study of factors influencing granulocyte light emission. J Immunol Methods. 1978;19:279-287.
38. Schopf RE, Mattar J, Meyenburg W, Scheiner O, Hammann KP, Lemmel EM. Measurement of the respiratory burst in human monocytes and polymorphonuclear leukocytes by nitro blue tetrazolium reduction and chemiluminescence. J Immunol Methods. 1984;67:109-117.
39. Figueroa DJ, Breyer RM, Defoe SK, et al. Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am J Respir Crit Care Med. 2001; 163:226-233.
40. Vandenberg PA, Ceuppens JL. Flow cytometric measurement of cytoplasmic free calcium in human peripheral blood T-lymphocytes with fluo-3, a new fluorescent calcium indicator. J Immunol Methods. 1990;127:197-205.
41. Tsien RY, Pozzan T, Rink TJ. Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator. J Cell Biol. 1982;94:325-334.
42. Kim CH, Broxmeyer HE. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood. 1998;91:100-110.
43. Howard TH, Meyer WH. Chemotactic peptide modulation of actin assembly and locomotion in neutrophils. J Cell Biol. 1984;98:1265-1271.
44. Konig W, Schonfeld W, Raulf M, et al. The neutrophil and leukotrienes-role in health and disease. Eicosanoids. 1990;3:1-22.
45. Rusten LS, Jacobsen SE, Kaalhus O, Vaiby OP, Funderud S, Smeland EB. Functional differences between CD38- and DR- subfractions of CD34+ bone marrow cells. Blood. 1994;84:1473-1481.
46. Sutherland HJ, Eaves CJ, Eaves AC, Dragowska W, Lansdorp PM. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood. 1989;74:1563-1570.
47. Terstappen LW, Huang S, Safford M, Lansdorp PM, Loken MR. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. Blood. 1991;77:1218-1227.
48. Issaad C, Croisille L, Katz A, Vainchenker W, Coulombel L. A murine stromal cell line allows the proliferaton of very primitive human CD34+ +/ CD38- progenitor cells in long-term cultures and semisolid assays. Blood. 1993;81:2916-2924.
49. Wang JF, Park IW, Groopman JE. Stromal cell-derived factor 1alpha stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: roles of phosphoinositide-3 kinase and protein kinase C. Blood. 2000;95: 2505-2513.
50. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol. 1994;55:97-179.
51. Forster R, Kremmer E, Schubel A, et al. Intracellular and surface expression of the HIV-1 coreceptor CXCR4/fusin in various leukocyte subsets: rapid internalization and recycling upon activation. J Immunol 1998;160:1522-1531.
52. Kawabata K, Ujikawa M, Edawa T, et al. A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution. Proc Natl Acad Sci U S A. 1999;96:5663-5667.
53. Ma Q, Jones D, Springer TA. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity. 1999; 10:463-471.
54. Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoiesis and bone marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature. 1996;382: 635-638.
55. Kozubik A, Hofmanova J, Pospisil M, Netikova J, Hola J, Lojek A. Effects of drugs inhibiting prostaglandin or leukotriene biosynthesis on postirradiation haematopoiesis in mouse. Int J Radiat Biol. 1994;65:369-377.
56. Roberts PJ, Mollapour E, Watts MJ, Linch DC. Primitive myeloid cells express high levels of phospholipase A(2) activity in the absence of leukotriene release: selective regulation by stem cell factor involving the MAP kinase pathway. Blood. 1999;94:1261-1272.
57. Zou JR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. Function of the chemokine receptor CXCR4 in haematopoiesis and cerebellar development. Nature. 1998;393:595-599.
58. Tachibana K, Hirota S, lizasa H, et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature. 1998;393:591-594.